Company intelligence / Profile preview

Neula Holding

Holzkirchen, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Neula Holding is a German private holding company rather than an operating biotech, pharma, or healthcare developer. Public business registry sources describe its purpose as acquiring and managing shareholdings and administering its own assets. Available evidence links the entity to the historical name Neuraxpharm Holding GmbH, suggesting it functions as a corporate holding structure connected to broader pharmaceutical ownership history rather than as a standalone drug development company. No evidence was found that Neula Holding itself runs a therapeutic pipeline, commercial healthcare products, or R&D programs.

Industry: Investors

Beyond the preview

Go deeper on Neula Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neula Holding.

Explore the full profile